Patents by Inventor Farooq Nasar

Farooq Nasar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant isfahan viral vectors
    Patent number: 9932564
    Abstract: Certain embodiments are directed to recombinant vesiculovirus encoding a heterologous polynucleotide and methods of using the same.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: April 3, 2018
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, PROFECTUS BIOSCIENCES, INC.
    Inventors: Demetrius Matassov, Rodion V. Gorchakov, Stefan Hamm, Rebecca Nowak, Robert L. Seymour, John H. Eldridge, Robert B. Tesh, David K. Clarke, Theresa E. Latham, Scott Weaver, Farooq Nasar
  • Alphavirus compositions and methods of use
    Patent number: 9683244
    Abstract: Embodiments are directed compositions related to Eilat virus and uses thereof.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: June 20, 2017
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Scott C. Weaver, Farooq Nasar, Rodion V. Gorchakov, Hilda Guzman, Naomi Forrester, Gustavo Palacios, Ian W. Lipkin, Robert B. Tesh
  • Alphavirus compositions and methods of use
    Patent number: 9422529
    Abstract: Embodiments are directed compositions related to Eilat virus and uses thereof. Certain aspects are directed to the detection of non-Eilat entities using a chimeric Eilat alphavirus as a capture agent.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: August 23, 2016
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Farooq Nasar, Jesse Erasmus, Scott C. Weaver
  • Compositions and methods related to viruses of the genus
    Patent number: 9388428
    Abstract: Certain embodiments are directed to Negevirus and their polynucleotides and polypeptides.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: July 12, 2016
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Farooq Nasar, Rodion V. Gorchakov, Andrew D. Haddow, Robert B. Tesh, Hilda Guzman, Scott C. Weaver
  • Alphavirus Compositions and Methods of Use
    Publication number: 20150175975
    Abstract: Embodiments are directed compositions related to Eilat virus and uses thereof. Certain aspects are directed to the detection of non-Eilat entities using a chimeric Eilat alphavirus as a capture agent.
    Type: Application
    Filed: October 28, 2014
    Publication date: June 25, 2015
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Farooq Nasar, Jesse Erasmus, Scott C. Weaver
  • COMPOSITIONS AND METHODS RELATED TO VIRUSES OF THE GENUS NEGEVIRUS
    Publication number: 20140227765
    Abstract: Certain embodiments are directed to Negevirus and their polynucleotides and polypeptides.
    Type: Application
    Filed: November 21, 2013
    Publication date: August 14, 2014
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Farooq Nasar, Rodion V. Gorchakov, Andrew D. Haddow, Robert B. Tesh, Hilda Guzman, Scott C. Weaver
  • Alphavirus Compositions and Methods of Use
    Publication number: 20140056938
    Abstract: Embodiments are directed compositions related to Eilat virus and uses thereof.
    Type: Application
    Filed: June 21, 2013
    Publication date: February 27, 2014
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Scott C. Weaver, Farooq Nasar, Rodion V. Gorchakov, Hilda Guzman, Naomi Forrester, Gustavo Palacios, Ian W. Lipkin, Robert B. Tesh
  • HETEROLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN
    Publication number: 20090092635
    Abstract: The present invention is directed to a method for generating an antigen-specific immune response in a subject in general and in particular to administering a priming dose of an immunogenic composition of a recombinant mumps virus (rMuV) that encodes an antigen followed by administering a boosting dose of recombinant vesicular stomatitis virus (rVSV) encoding an antigen.
    Type: Application
    Filed: August 15, 2008
    Publication date: April 9, 2009
    Applicant: WYETH
    Inventors: David Kirkwood Clarke, Farooq Nasar, Rong Xu, Shakuntala Devi Megati, Michael Albin Egan, Amara Gbellu Luckay